Fusion of EWSR1 with the DUX4 facioscapulohumeral muscular dystrophy region resulting from t(4;22)(q35;q12) in a case of embryonal rhabdomyosarcoma

Cancer Genetics and Cytogenetics

Volumn 195, Issue 1, 2009, Pages 12-18

  Sirvent, Nicolas ^a,b   Trassard, Martine ^c   Ebran, Nathalie ^a,b   Attias, Rita ^a,b   Pedeutour, Florence ^a,b  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CENTRE DE BIOCHIMIE   (France)

^c Cancer Research Center Rene Huguenin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; PROTEIN DUX1; RNA BINDING PROTEIN EWS DOUBLE HOMEDOMAIN 1 FUSION PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER SURGERY; CASE REPORT; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 35; CHROMOSOME TRANSLOCATION 4; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYTOGENETICS; DISEASE DURATION; EMBRYONAL RHABDOMYOSARCOMA; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARTORIUS MUSCLE;

ADULT; CALMODULIN-BINDING PROTEINS; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 4; CYTOGENETIC ANALYSIS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSCOPY, ELECTRON; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; RHABDOMYOSARCOMA, EMBRYONAL; RNA-BINDING PROTEINS; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 70349882109     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.06.011     Document Type: Article

References (31)

1. Parham D.M., and Ellison D.A. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med 130 (2006) 1454-1465
2. Shapiro D.N., Sublett J.E., Li B., Downing J.R., and Naeve C.W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53 (1993) 5108-5112
3. Davis R.J., D'Cruz C.M., Lovell M.A., Biegel J.A., and Barr R.G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54 (1994) 2869-2872
4. Sorensen P.H., Lynch J.C., Qualman S.J., Tirabosco R., Lim J.F., Maurer H.M., Bridge J.A., Christ W.M., Triche T.J., and Barre F.G. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report of the Children's Oncology Group. J Clin Oncol 20 (2002) 2672-2679
5. Mertens F., Fletcher C.D., Dal Cin P., De Wever I., Mandahl N., Mitelman F., Rosai J., Rydholm A., Sciot R., Tallini G., Van den Berghe H., Vanni R., Willén H., and CHAMP Study Group. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features. Genes Chromosomes Cancer 22 (1998) 16-25
6. Anderson J., Gordon A., Pritchard-Jones K., and Shipley J. Genes, chromosomes and rhabdomyosarcoma. Genes Chromosomes Cancer 26 (1999) 275-285
7. Scrable H., Witte D., Shimada H., Seemayer T., Sheng W.W., Soukup S., Koufos A., Houghton P., Lampkin B., and Cavenee W. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer 1 (1989) 23-25
8. Anderson J., Gordon A., McManus A., Shipley J., and Pritchard-Jones K. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia 1 (1999) 340-348
9. Bridge J.A., Liu J., Qualman S., Suijkerbuijk R., Wenger G., Zhang J., Wan X., Baker K., Sorensen P., and Barr F. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 33 (2000) 310-321
10. Kapels K.M., Nishio J., Zhou M., Qualman S.J., and Bridge J.A. Embryonal rhabdomyosarcoma with a der(16)t(1;16) translocation. Cancer Genet Cytogenet 174 (2007) 68-73
11. Ho R., Johnson J., Dev V.G., and Whitlock J. A novel t(2;20)(q35;p12) in embryonal rhabdomyosarcoma. Cancer Genet Cytogenet 151 (2004) 73-77
12. Urumov I.J., and Manolova Y. Cytogenetic analysis of an embryonal rhabdomyosarcoma cell line. Cancer Genet Cytogenet 61 (1992) 214-215
13. Richkind K.E., Romansky S.G., and Finklestein J.Z. t(4;19)(q35;q13.1): a recurrent change in primitive mesenchymal tumors?. Cancer Genet Cytogenet 87 (1996) 71-74
14. Roberts P., Browne C.F., Lewis I.J., Bailey C.C., Spicer R.D., Williams J., and Batcup G. 12q13 abnormality in rhabdomyosarcoma: a nonrandom occurrence?. Cancer Genet Cytogenet 60 (1992) 135-140
15. Limon J., Dal Cin P., and Sandberg A.A. Application of long term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23 (1986) 305-312
16. Sirvent N., Forus A., Lescaut W., Burel F., Benzaken S., Chazal M., Bourgeon A., Vermeesch J.R., Myklebost O., Turc-Carel C., Ayraud N., Coindre J.M., and Pedeutour F. Characterization of centromere alterations in liposarcomas. Genes Chromosomes Cancer 29 (2000) 117-129
17. Tam R., Smith K.P., and Lawrence J.B. The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres. J Cell Biol 167 (2004) 269-279
18. Delattre O., Zucman J., Melot T., Garau X.S., Zucker J.M., Lenoir G.M., Ambros P.F., Sheer D., Turc-Carel C., Triche T.J., Aurias A., and Thomas G. The Ewing family of tumors: a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331 (1994) 294-299
19. Ladanyi M., and Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54 (1994) 2837-2840
20. Zucman J., Delattre O., Desmaze C., Epstein A.L., Stenman G., Speleman F., Fletcher C.D.M., Aurias A., and Thomas G. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4 (1993) 341-345
21. Panagopoulos I., Höglund M., Mertens F., Mandahl N., Mitelman F., and Aman P. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 12 (1996) 489-494
22. Bernstein M., Kovar H., Paulussen M., Lor Randall R., Schuck A., Teot L.A., and Jürgens H. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 5th ed (2005), Lippincott Williams & Wilkins, Philadelphia 1002-1028
23. Gabriëls J., Beckers M.C., Ding H., De Vriese A., Plaisance S., van der Maarel S.M., Padberg G.W., Frants R.R., Hewitt J.E., Collen D., and Belayew A. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236 (1999) 25-32
24. Wijmenga C., Hewitt J.E., Sandkuijl L.A., Clark L.N., Wright T.J., Dauwerse H.G., Gruter A.M., Hofker M.H., Moerer P., Williamson R., van Ommen G.J.B., Padberg G.W., and Frants R.R. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 2 (1992) 26-30
25. Winokur S.T., Chen Y.W., Masny P.S., Martin J.H., Ehmsen J.T., Tapscott S.J., van der Maarel S.M., Hayashi Y., and Flanigan K.M. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 22 (2003) 2895-2907
26. Ding H., Beckers M.C., Plaisance S., Marynen P., Collen D., and Belayew A. Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elements. Hum Mol Genet 11 (1998) 1681-1694
27. Kawamura-Saito M., Yamazaki Y., Kaneko K., Kawaguchi N., Kanda H., Mukai H., Gotoh T., Motoi T., Fukayama M., Aburatani H., Takizawa T., and Nakamura T. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 13 (2006) 2125-2137
28. de Launoit Y., Chotteau-Leloevre A., Beaudoin C., Coutte L., Netzer S., Brenner C., Huvent I., and Baert J. The PEA3 group of ETS-related transcription factors: role in breast cancer metastasis. Adv Exp Med Biol 480 (2000) 107-116
29. Davidson B., Goldberg I., Gotlieb W., Kopolovic J., Ben-Baruch G., and Reich R. PEA3 is the second ETS family transcription factor involved in tumor progression in ovarian carcinoma. Clin Cancer Res 9 (2003) 1412-1419
30. Horiuchi S., Yamamoto H., Min Y., Adachi Y., Itoh F., and Imai K. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J Pathol 200 (2003) 568-576
31. Tirode F., Laud-Duval K., Prieur A., Delorme B., Charbord P., and Delattre O. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11 (2007) 421-429